Used in research settings to inhibit c-Myc, a transcription factor involved in cell proliferation and tumorigenesis. It is primarily applied in cancer studies to explore the effects of c-Myc suppression on tumor growth and apoptosis. Shows activity in reducing viability of cancer cells in vitro, particularly in hematological malignancies and solid tumors. Also utilized in combination therapies to enhance the efficacy of other anticancer agents by targeting oncogenic signaling pathways. Due to poor pharmacokinetic properties, it is mainly restricted to laboratory use and not used clinically.